Is CMPS up or down today?
CMPS is up 2.73% today, last at 8.64. This stock moved +2.73% versus the prior close.
CMPS · CMPS
CMPS (CMPS) is trading at 8.64, up 2.73% on the session. CMPS sits at the 34% mark of its 52-week range, carries a 14-day RSI of 30, and trades below its 50-day average. Over the past month it is down 27.39%.
Leading the coverage: “Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress” (Yahoo, 6d ago). CMPS is -26.84% since story.
CMPS trades on a trailing P/E of 24.6 and is running 25.33% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
CMPS is up 2.73% today, last at 8.64. This stock moved +2.73% versus the prior close.
Leading the coverage: “Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress” (Yahoo, 6d ago). CMPS is -26.84% since story. Dominant story: Compass Pathways stock maintained at Buy by TD Cowen ahead of NDA filing - Investing.com UK (1 source, neutral) RSI is 30 — leaning bearish Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Compass Pathways stock maintained at Buy by TD Cowen ahead of NDA filing - Investing.com UK
Compass Pathways outlines potential 30- to 60-day FDA review target as it plans to complete COMP360 NDA in next 2 weeks
Earnings call transcript: COMPASS Pathways beats Q3 2026 loss estimate By Investing.com - Investing.com Nigeria
Compass Pathways Q3 Earnings Call Highlights
Compass Pathways Q3 Earnings Call Highlights - Yahoo Finance